949 related articles for article (PubMed ID: 24994869)
1. Antioxidant and inflammatory cytokine in tears of patients with dry eye syndrome treated with preservative-free versus preserved eye drops.
Jee D; Park SH; Kim MS; Kim EC
Invest Ophthalmol Vis Sci; 2014 Jul; 55(8):5081-9. PubMed ID: 24994869
[TBL] [Abstract][Full Text] [Related]
2. Comparison of treatment with preservative-free versus preserved sodium hyaluronate 0.1% and fluorometholone 0.1% eyedrops after cataract surgery in patients with preexisting dry-eye syndrome.
Jee D; Park M; Lee HJ; Kim MS; Kim EC
J Cataract Refract Surg; 2015 Apr; 41(4):756-63. PubMed ID: 25487027
[TBL] [Abstract][Full Text] [Related]
3. Additive Effect of preservative-free sodium hyaluronate 0.1% in treatment of dry eye syndrome with diquafosol 3% eye drops.
Hwang HS; Sung YM; Lee WS; Kim EC
Cornea; 2014 Sep; 33(9):935-41. PubMed ID: 25055152
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of hypotonic 0.18% sodium hyaluronate eye drops in patients with dry eye disease.
Lee HS; Ji YS; Yoon KC
Cornea; 2014 Sep; 33(9):946-51. PubMed ID: 24915018
[TBL] [Abstract][Full Text] [Related]
5. A comparison of vitamin a and cyclosporine a 0.05% eye drops for treatment of dry eye syndrome.
Kim EC; Choi JS; Joo CK
Am J Ophthalmol; 2009 Feb; 147(2):206-213.e3. PubMed ID: 18848318
[TBL] [Abstract][Full Text] [Related]
6. Effect of changing from preserved prostaglandins to preservative-free tafluprost in patients with glaucoma on tear film thickness.
Hommer A; Schmidl D; Kromus M; Bata AM; Fondi K; Werkmeister RM; Baar C; Schmetterer L; Garhöfer G
Eur J Ophthalmol; 2018 Jul; 28(4):385-392. PubMed ID: 29592773
[TBL] [Abstract][Full Text] [Related]
7. Comparison of autologous serum and umbilical cord serum eye drops for dry eye syndrome.
Yoon KC; Heo H; Im SK; You IC; Kim YH; Park YG
Am J Ophthalmol; 2007 Jul; 144(1):86-92. PubMed ID: 17493572
[TBL] [Abstract][Full Text] [Related]
8. The Effect of Tear Supplementation with 0.15% Preservative-Free Zinc-Hyaluronate on Ocular Surface Sensations in Patients with Dry Eye.
Perényi K; Dienes L; Kornafeld A; Kovács B; Kiss HJ; Szepessy Z; Nagy ZZ; Barsi Á; Acosta MC; Gallar J; Kovács I
J Ocul Pharmacol Ther; 2017; 33(6):487-492. PubMed ID: 28375789
[TBL] [Abstract][Full Text] [Related]
9. Effects of topical cyclosporine a plus artificial tears versus artificial tears treatment on conjunctival goblet cell density in dysfunctional tear syndrome.
Demiryay E; Yaylali V; Cetin EN; Yildirim C
Eye Contact Lens; 2011 Sep; 37(5):312-5. PubMed ID: 21792057
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of cyclosporine 0.05% drops versus unpreserved artificial tears in dry-eye patients having laser in situ keratomileusis.
Salib GM; McDonald MB; Smolek M
J Cataract Refract Surg; 2006 May; 32(5):772-8. PubMed ID: 16765793
[TBL] [Abstract][Full Text] [Related]
11. [Therapeutic effects of Pyranoprofen on the mouse dry eye induced by topical medication of Benzalkonium Chloride].
He H; Liu ZG; Lin ZR; Liu XC; He H; Xiao QG
Zhonghua Yan Ke Za Zhi; 2012 Jan; 48(1):33-40. PubMed ID: 22490914
[TBL] [Abstract][Full Text] [Related]
12. Iatrogenic dry eye disease: an eledoisin/carnitine and osmolyte drops study.
Nebbioso M; Evangelista M; Librando A; Plateroti AM; Pescosolido N
Biomed Pharmacother; 2013 Sep; 67(7):659-63. PubMed ID: 23906760
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of combined 0.05% cyclosporine and 1% methylprednisolone treatment for chronic dry eye.
Byun YJ; Kim TI; Kwon SM; Seo KY; Kim SW; Kim EK; Park WC
Cornea; 2012 May; 31(5):509-13. PubMed ID: 19730097
[TBL] [Abstract][Full Text] [Related]
14. Tear clearance and ocular symptoms in patients treated with preservative-free prostaglandins.
Giménez-Gómez R; García-Catalán MR; Gallardo-Galera JM
Arch Soc Esp Oftalmol; 2013 Mar; 88(3):88-91. PubMed ID: 23473084
[TBL] [Abstract][Full Text] [Related]
15. Tear osmolarity measurement using the TearLab Osmolarity System in the assessment of dry eye treatment effectiveness.
Benelli U; Nardi M; Posarelli C; Albert TG
Cont Lens Anterior Eye; 2010 Apr; 33(2):61-7. PubMed ID: 20153684
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the clinical course of dry eye syndrome.
Horwath-Winter J; Berghold A; Schmut O; Floegel I; Solhdju V; Bodner E; Schwantzer G; Haller-Schober EM
Arch Ophthalmol; 2003 Oct; 121(10):1364-8. PubMed ID: 14557170
[TBL] [Abstract][Full Text] [Related]
17. Comparison of autologous serum eye drops with different diluents.
Cho YK; Huang W; Kim GY; Lim BS
Curr Eye Res; 2013 Jan; 38(1):9-17. PubMed ID: 22928476
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of using preservative-free artificial tears versus preserved lubricants for the treatment of dry eyes: a systematic review.
Ribeiro MVMR; Barbosa FT; Ribeiro LEF; Sousa-Rodrigues CF; Ribeiro EAN
Arq Bras Oftalmol; 2019 Sep; 82(5):436-445. PubMed ID: 31508669
[TBL] [Abstract][Full Text] [Related]
19. Effect of chitosan-N-acetylcysteine conjugate in a mouse model of botulinum toxin B-induced dry eye.
Hongyok T; Chae JJ; Shin YJ; Na D; Li L; Chuck RS
Arch Ophthalmol; 2009 Apr; 127(4):525-32. PubMed ID: 19365035
[TBL] [Abstract][Full Text] [Related]
20. Effects of lubricating agents with different osmolalities on tear osmolarity and other tear function tests in patients with dry eye.
Cömez AT; Tufan HA; Kocabıyık O; Gencer B
Curr Eye Res; 2013 Nov; 38(11):1095-103. PubMed ID: 23841565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
